EILEEN MCKEON: Open Payments
NPI 1477768877 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$250 in 13 payments from 11 companies in 2025. Trend: 2023 $789 · 2024 $1,269 · 2025 $250
Food & beverage: $250
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $45 |
| Lilly USA, LLC | 1 | $22 |
| Medtronic, Inc. | 1 | $22 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| HEARTFLOW, INC. | 1 | $17 |
| Abbott Laboratories | 1 | $17 |
| Almatica Pharma LLC | 1 | $16 |
| PFIZER INC. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: LEQVIO, QULIPTA, MOUNJARO, INCEPTIV, VRAYLAR, ZENPEP, FFRct, FREESTYLE LIBRE 3.
Industry payments across MO — which companies pay providers there.
